DBV Technologies (France) Profile

37.92
EUR 0.22  0.58%
62%
25%

DBV Technologies Summary

DBV Technologies S A (DBV) is traded on Paris Stock Exchange in France. It is located in 177-181 avenue Pierre Brossolette and employs 244 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.15 B. DBV Technologies S A operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 29.71 M outstanding shares. DBV TECHNOLOGIES has accumulated about 137.88 M in cash with (114.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.52.
Check DBV Technologies Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 76.75%30 days 37.92  about 23.2%
Based on normal probability distribution, the odds of DBV Technologies to move above current price in 30 days from now is about 23.2% (This DBV Technologies S A probability density function shows the probability of DBV Technologies Stock to fall within a particular range of prices over 30 days) .

Top Holders

DBV Technologies S Risk Profiles

Key Fundamentals

DBV Technologies Against Markets

Current Ratings

DBV Technologies 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
3 
Chance of
Financial Distress (0 to 100%)
< 50% 
Equity ratings for DBV Technologies S A are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in France and traded on Paris Stock Exchange. It employs 244 people. more
NameDBV Technologies S A
Chairman of the Board, CEOPierreHenri BenhamouView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentFrance Stock View All
Business Address177-181 avenue Pierre Brossolette
Foreign Associates
ExchangeParis Stock Exchange
ISINFR0010417345
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.dbv-technologies.com
Contact Number33 1 55 42 78 78
CurrencyEUR - Euro

Diversify with DBV Technologies S A

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add DBV Technologies S A to your portfolio

Directors

DBV Technologies Corporate Directors
Rafaele Tordjman Director - Representative of Sofinnova Partners
Pascale Ehouarn Industrial Development and Production Director
Claude Thebault Medical Director
Additionally see Investing Opportunities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.